1. Home
  2. NDRA vs NUAIW Comparison

NDRA vs NUAIW Comparison

Compare NDRA & NUAIW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • NDRA
  • NUAIW
  • Stock Information
  • Founded
  • NDRA 2007
  • NUAIW N/A
  • Country
  • NDRA United States
  • NUAIW United States
  • Employees
  • NDRA N/A
  • NUAIW N/A
  • Industry
  • NDRA Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • NUAIW
  • Sector
  • NDRA Health Care
  • NUAIW
  • Exchange
  • NDRA Nasdaq
  • NUAIW Nasdaq
  • Market Cap
  • NDRA 2.3M
  • NUAIW 2.1M
  • IPO Year
  • NDRA 2017
  • NUAIW N/A
  • Fundamental
  • Price
  • NDRA $4.39
  • NUAIW $0.08
  • Analyst Decision
  • NDRA Strong Buy
  • NUAIW
  • Analyst Count
  • NDRA 1
  • NUAIW 0
  • Target Price
  • NDRA $46.00
  • NUAIW N/A
  • AVG Volume (30 Days)
  • NDRA 63.2K
  • NUAIW N/A
  • Earning Date
  • NDRA 08-14-2025
  • NUAIW N/A
  • Dividend Yield
  • NDRA N/A
  • NUAIW N/A
  • EPS Growth
  • NDRA N/A
  • NUAIW N/A
  • EPS
  • NDRA N/A
  • NUAIW N/A
  • Revenue
  • NDRA N/A
  • NUAIW N/A
  • Revenue This Year
  • NDRA N/A
  • NUAIW N/A
  • Revenue Next Year
  • NDRA N/A
  • NUAIW N/A
  • P/E Ratio
  • NDRA N/A
  • NUAIW N/A
  • Revenue Growth
  • NDRA N/A
  • NUAIW N/A
  • 52 Week Low
  • NDRA $2.90
  • NUAIW N/A
  • 52 Week High
  • NDRA $25.90
  • NUAIW N/A
  • Technical
  • Relative Strength Index (RSI)
  • NDRA 40.24
  • NUAIW N/A
  • Support Level
  • NDRA $4.42
  • NUAIW N/A
  • Resistance Level
  • NDRA $4.92
  • NUAIW N/A
  • Average True Range (ATR)
  • NDRA 0.36
  • NUAIW 0.00
  • MACD
  • NDRA -0.03
  • NUAIW 0.00
  • Stochastic Oscillator
  • NDRA 28.88
  • NUAIW 0.00

About NDRA ENDRA Life Sciences Inc.

ENDRA Life Sciences Inc is engaged in the development of Thermo Acoustic Enhanced UltraSound (TAEUS) to visualize tissue like MRI at the cost and at the point of patient care. TAEUS is designed to work in concert with around 400,000 cart-based ultrasound systems in use globally today. TAEUS is initially focused on the measurement of fat in the liver as a means to assess and monitor Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH), chronic liver conditions that affect over one billion people globally, and for which there are no practical diagnostic tools. Beyond the liver, the firm is exploring several other clinical applications of TAEUS, including visualization of tissue temperature during energy-based surgical procedures.

Share on Social Networks: